drugset / Trial / NCT07528495
A Trial Evaluating Omission of Radiotherapy to Regional Lymphatic's
Phase 2/3
Recruiting
396 enrolled
All India Institute of Medical Sciences
All India Institute of Medical Sciences, Raipur · collabAll India Institute of Medical Sciences, Rishikesh · collabJawaharlal Institute of Postgraduate Medical Education & Research · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The present study is a phase II/III prospective randomized trial designed to determine whether eliminating of post operative radiotherapy to regional lymphatics in pN0-N1oral cavity is associated with similar treatment outcomes.
Timeline
- Start
- 2024-04-03
- Primary completion
- 2027-12-30
- Completion
- 2028-04-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cisplatin | Other / unclassified | 40 mg/m2 | — |